Date published: 2026-3-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tetanus Toxoid, Clostridium tetani

0.0(0)
Write a reviewAsk a question

Alternate Names:
Tetanus Toxoid
Application:
Tetanus Toxoid, Clostridium tetani is a compound formed by formaldehyde inactivation of the tetanus toxin
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Tetanus Toxoid, Clostridium tetani is prepared with formaldehyde inactivation of the tetanus toxin. Tetanus Toxoid, Clostridium tetani has been determined to be non-toxic by an LD50 assay in mice. Lyophilized from 100 mM histidine, 100 mM NaCl, 5% trehalose, pH 7.0.


Tetanus Toxoid, Clostridium tetani References

  1. The genome sequence of Clostridium tetani, the causative agent of tetanus disease.  |  Bruggemann, H., et al. 2003. Proc Natl Acad Sci U S A. 100: 1316-21. PMID: 12552129
  2. The role of reduced iron powder in the fermentative production of tetanus toxin.  |  Demain, AL., et al. 2006. Appl Microbiol Biotechnol. 73: 55-9. PMID: 16622677
  3. Menstrum for culture preservation and medium for seed preparation in a tetanus toxin production process containing no animal or dairy products.  |  Fang, A., et al. 2006. Lett Appl Microbiol. 43: 360-3. PMID: 16965364
  4. [Production and immunogenicity analysis of conformation-stable fragment-C mutant of tetanus toxin].  |  Yu, R., et al. 2011. Sheng Wu Gong Cheng Xue Bao. 27: 226-32. PMID: 21650047
  5. An asymmetric and slightly dimerized structure for the tetanus toxoid protein used in glycoconjugate vaccines.  |  Abdelhameed, AS., et al. 2012. Carbohydr Polym. 90: 1831-5. PMID: 22944454
  6. Tetanus following replantation of an amputated finger: a case report.  |  Hayashida, K., et al. 2012. J Med Case Rep. 6: 343. PMID: 23043848
  7. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.  |  Yousefi, M., et al. 2014. J Immunotoxicol. 11: 28-34. PMID: 23369087
  8. Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen of Vibrio cholerae, serotype Ogawa and the recombinant tetanus toxin C-fragment carrier.  |  Jahouh, F., et al. 2013. J Mass Spectrom. 48: 1083-90. PMID: 24130011
  9. [Shiga toxin and tetanus toxin as a potential biologic weapon].  |  Toczyska, I. and Płusa, T. 2015. Pol Merkur Lekarski. 39: 157-61. PMID: 26449578
  10. Insights into Clostridium tetani: From genome to bioreactors.  |  Garrigues, L., et al. 2022. Biotechnol Adv. 54: 107781. PMID: 34029623
  11. Molecular pharmacology of botulinum toxin and tetanus toxin.  |  Simpson, LL. 1986. Annu Rev Pharmacol Toxicol. 26: 427-53. PMID: 3521461
  12. Tetanus toxin. The effect of chemical modifications on toxicity, immunogenicity, and conformation.  |  Robinson, JP., et al. 1975. J Biol Chem. 250: 7435-42. PMID: 809435
  13. Nitrogen-gas bubbling during the cultivation of Clostridium tetani produces a higher yield of tetanus toxin for the preparation of its toxoid.  |  De Luca, MM., et al. 1997. Microbiol Immunol. 41: 161-3. PMID: 9087958

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Tetanus Toxoid, Clostridium tetani, 25 µg

sc-494591
25 µg
$474.00